Evidence map›Paper›PMID 37600544›Full record

ArticleHealth promotion perspectives2023

Use and outcomes of antihypertensive medication treatment in the US hypertensive population: A gender comparison.

Shakir Ullah, Shahbaz Khan, Shahrzad Bazargan-Hejazi, Ernesto Ramirez, Senait Teklehaimanot, Sara Diab, Maria Bangash, Magda Shaheen

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Health promotion perspectives, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Shakir UllahCharles R. Drew University of Medicine and Science and David Geffen School of Medicine, University of California at Los Angeles, CA, USA.ORCID https://orcid.org/0000-0002-3480-4475
Shahbaz KhanAyub Medical College and Teaching Hospital, Abbottabad, Pakistan.ORCID https://orcid.org/0000-0002-1039-0634
Shahrzad Bazargan-HejaziCharles R. Drew University of Medicine and Science and David Geffen School of Medicine, University of California at Los Angeles, CA, USA.ORCID https://orcid.org/0000-0001-8361-5198
Ernesto RamirezCharles R. Drew University of Medicine and Science and David Geffen School of Medicine, University of California at Los Angeles, CA, USA.
Senait TeklehaimanotCharles R. Drew University of Medicine and Science and David Geffen School of Medicine, University of California at Los Angeles, CA, USA.
Sara DiabUniversity of California, Irvine, CA, USA.
Maria BangashSouthern California University of Health and Sciences, CA, USA.
Magda ShaheenCharles R. Drew University of Medicine and Science and David Geffen School of Medicine, University of California at Los Angeles, CA, USA.
University of California, Los Angeles · USAyub Medical College · PKSouthern California University of Health Sciences · USUniversity of California, Irvine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Although effective antihypertensive medications have existed for decades, only about half of the hypertensive individuals are considered to have controlled blood pressure. Limited research studies have investigated gender disparity in the utilization and effectiveness of antihypertensive medications treatment. To examine the gender difference in antihypertensive medications' use and the effect of using antihypertensive medication treatment on blood pressure control among the U.S. adult with hypertension. Methods: Analysis of National Health and Nutrition Examination Survey (NHANES) data from (1999-2012) including individuals≥18 years old with hypertension. Study variables included gender, age, race/ethnicity, obesity, smoking, comorbidities, treatment medication type, and continuity of care. We used multivariate logistic regression in STATA V14. The data is presented as adjusted odds ratios (ORs) and 95% confidence interval (CI). Results: Of the 15719 participants, 52% were female. 49% of the antihypertensive medication users had their blood pressure under control (95% CI). In the adjusted logistic regression analysis, use of antihypertensive medications was found to be 12% greater in females as compared to males (OR=1.12; CI=1.02-1.22; Conclusion: Hypertensive females are more likely than males to use antihypertensive medications. The effectiveness of treatment to control blood pressure is equal across males and females. Our findings have implications for practitioners to account gender-specific approaches when discussing adherence to hypertension medication treatment with their patients.

Indexed as

Antihypertensive agentsBlood pressure controlComorbidityGender differencesHypertensionMedication adherenceRacial disparities

Identifiers

PMID37600544
PMCPMC10439450
OpenAlexW4385075501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.